← Eichor
Condition: Low Grade Upper Tract Urothelial Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Low Grade Upper Tract Urothelial Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · 62 location(s) · UroGen Pharma Ltd. · NCT06774131Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
Phase 1/Phase 2 · 9 location(s) · Ferring Pharmaceuticals · NCT06668493Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
Phase 2 · 15 location(s) · Tyra Biosciences, Inc · NCT07265947
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.